This company offers custom 3D bioprinting services and develops specialized bio-inks for research applications. They enable institutions to explore bioprinting for tissue engineering and regenerative medicine without requiring in-house expertise.
Funding
Funding not disclosed
Founders
Product
Problem
Many research institutions and medical facilities lack the in-house expertise and specialized equipment required to effectively utilize 3D bioprinting for tissue engineering and regenerative medicine research. This limits their ability to explore the potential of bioprinting for creating functional tissues and medical solutions.
Solution
Kore Additive Manufacturing and Medical Reconstruction (Koreammr) provides custom 3D bioprinting services and develops specialized bio-inks to enable institutions to advance research in tissue engineering and regenerative medicine. The company offers custom 3D-printed scaffolds, develops bio-inks that mimic natural tissue environments, and provides cell culture studies on ATCC cell lines. Koreammr also offers organ-on-a-chip systems for drug testing and disease modeling, along with consultation and hands-on training programs for setting up 3D bioprinting facilities.
Target Audience
Koreammr serves researchers, institutions, healthcare professionals, and industry partners involved in tissue engineering, regenerative medicine, and drug discovery.
Features
- Custom 3D bioprinted scaffold development for surgical reconstruction
- Custom bio-ink formulation development to mimic natural tissue environments
- Cell culture studies on ATCC cell lines
- Organ-on-a-chip systems for drug testing and disease modeling
- Consultation services for 3D bioprinting facility setup
- Hands-on training programs in 3D bioprinting techniques
- Development of bio-compatible materials that support tissue growth and regeneration
- AI-powered additive manufacturing for enhanced precision and efficiency